SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-017941
Filing Date
2024-04-04
Accepted
2024-04-04 16:09:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20020401x2_defa14a.htm DEFA14A 8648
2 ny20020401x2_nc01.jpg GRAPHIC 433777
3 ny20020401x2_nc02.jpg GRAPHIC 317416
  Complete submission text file 0001140361-24-017941.txt   1044966
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 24823222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)